A prediction model for N2 disease in T1 non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 6, 2012, Pages 1360-1364

  Zhang, Yang ^a,b   Sun, Yihua ^a,b   Xiang, Jiaqing ^a,b   Zhang, Yawei ^a,b   Hu, Hong ^a,b   Chen, Haiquan ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; CANCER PATIENT; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; REVIEW; TUMOR VOLUME;

EID: 84869079468     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.06.050     Document Type: Article

References (24)

1. F.C. Detterbeck, D.J. Boffa, and L.T. Tanoue The new lung cancer staging system Chest 136 2009 260 271
2. D.S. Ettinger, W. Akerley, G. Bepler, M.G. Blum, A. Chang, and R.T. Cheney Non-small cell lung cancer J Natl Compr Canc Netw 8 2010 740 801
3. D.H. Kirn, T.J. Lynch, S.J. Mentzer, T.H. Lee, G.M. Strauss, and A.D. Elias Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. Impact of preoperative chemotherapy on resectability and downstaging J Thorac Cardiovasc Surg 106 1993 696 702
4. K.L. Uy, G. Darling, W. Xu, Q.L. Yi, M. De Perrot, and A.F. Pierre Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer J Thorac Cardiovasc Surg 134 2007 188 193
5. G.V. Gonzalez-Stawinski, A. Lemaire, F. Merchant, E. O'Halloran, R.E. Coleman, and D.H. Harpole A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer J Thorac Cardiovasc Surg 126 2003 1900 1905
6. H. Kramer, and H.J. Groen Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer Ann Surg 238 2003 180 188
7. F.C. Detterbeck, M.A. Jantz, M. Wallace, J. Vansteenkiste, and G.A. Silvestri Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 3 Suppl 2007 202S 220S
8. Y.S. Choi, Y.M. Shim, J. Kim, and K. Kim Mediastinoscopy in patients with clinical stage I non-small cell lung cancer Ann Thorac Surg 75 2003 364 366
9. S.A. Defranchi, S.D. Cassivi, F.C. Nichols, M.S. Allen, K.R. Shen, and C. Deschamps N2 disease in T1 non-small cell lung cancer Ann Thorac Surg 88 2009 924 928
10. O. Birim, A.P. Kappetein, T. Stijnen, and A.J. Bogers Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer Ann Thorac Surg 79 2005 375 382
11. C.E. Reed, D.H. Harpole, K.E. Posther, S.L. Woolson, R.J. Downey, and B.F. Meyers Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer J Thorac Cardiovasc Surg 126 2003 1943 1951
12. B.A. Whitson, S.S. Groth, and M.A. Maddaus Recommendations for optimal use of imaging studies to clinically stage mediastinal lymph nodes in non-small-cell lung cancer patients Lung Cancer 61 2008 177 185
13. B.D. Kozower, B.F. Meyers, C.E. Reed, D.R. Jones, P.A. Decker, and J.B. Putnam Jr. Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer? Ann Thorac Surg 85 2008 1166 1170
14. R.F. Kelly, T. Tran, A. Holmstrom, J. Murar, and R.J. Segurola Jr. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer Chest 125 2004 1413 1423
15. B.F. Meyers, F. Haddad, B.A. Siegel, J.B. Zoole, R.J. Battafarano, and N. Veeramachaneni Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer J Thorac Cardiovasc Surg 131 2006 822 829
16. W.D. Travis, E. Brambilla, M. Noguchi, A.G. Nicholson, K.R. Geisinger, and Y. Yatabe International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma J Thorac Oncol 6 2011 244 285
17. E.W. Steyerberg, F.E. Harrell Jr., G.J. Borsboom, M.J. Eijkemans, Y. Vergouwe, and J.D. Habbema Internal validation of predictive models: efficiency of some procedures for logistic regression analysis J Clin Epidemiol 54 2001 774 781
18. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
19. B.A. Dwamena, S.S. Sonnad, J.O. Angobaldo, and R.L. Wahl Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT Radiology 213 1999 530 536
20. S. Shafazand, and M.K. Gould A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer J Thorac Oncol 1 2006 953 959
21. P. De Leyn, J. Vansteenkiste, P. Cuypers, G. Deneffe, D. Van Raemdonck, and W. Coosemans Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan Eur J Cardiothorac Surg 12 1997 706 712
22. D.B. Flieder, J.L. Port, R.J. Korst, P.J. Christos, M.A. Levin, and D.E. Becker Tumor size is a determinant of stage distribution in t1 non-small cell lung cancer Chest 128 2005 2304 2308
23. L. DeCaro, and J.R. Benfield Lung cancer in young persons J Thorac Cardiovasc Surg 83 1982 372 376
24. K. Suzuki, K. Nagai, J. Yoshida, M. Nishimura, K. Takahashi, and Y. Nishiwaki Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer J Thorac Cardiovasc Surg 117 1999 593 598